Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction

OBJECTIVES: Macrolides are generally considered to be the drugs of choice for treatment of patients with Mycoplasma pneumoniae infection. However, macrolide-resistant M. pneumoniae has been emerging since about 2000. The Smart Gene(®) system (MIZUHO MEDY Co., Ltd., Tosu, Japan) is a novel fully auto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Nobuhisa, Sato, Rikako, Mori, Toshihiko, Tanaka, Hiroshi, Narita, Mitsuo, Nagano, Takashi, Owaku, Masato, Miyajima, Kensuke, Manabe, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516298/
https://www.ncbi.nlm.nih.gov/pubmed/34648603
http://dx.doi.org/10.1371/journal.pone.0258694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516298/
https://www.ncbi.nlm.nih.gov/pubmed/34648603
http://dx.doi.org/10.1371/journal.pone.0258694

Ejemplares similares